世界の進行性前立腺がん治療薬市場予測2023-2029:経口式、静脈注射式、その他

【英語タイトル】Advanced Prostate Cancer Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23FB2153)・商品コード:MMG23FB2153
・発行会社(調査会社):Market Monitor Global
・発行日:2023年2月
・ページ数:63
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の進行性前立腺がん治療薬市場規模と予測を収録しています。・世界の進行性前立腺がん治療薬市場:売上、2018年-2023年、2024年-2029年
・世界の進行性前立腺がん治療薬市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の進行性前立腺がん治療薬市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「経口式」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

進行性前立腺がん治療薬のグローバル主要企業は、Pfizer、Astellas、Janssen、AstraZeneca、Bayer、Hengrui、CTTQ、Sanofi、Hansoh、Clovis Oncology、Zhendong Pharmaceutical、Merckなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、進行性前立腺がん治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の進行性前立腺がん治療薬市場:タイプ別、2018年-2023年、2024年-2029年
世界の進行性前立腺がん治療薬市場:タイプ別市場シェア、2022年
・経口式、静脈注射式、その他

世界の進行性前立腺がん治療薬市場:用途別、2018年-2023年、2024年-2029年
世界の進行性前立腺がん治療薬市場:用途別市場シェア、2022年
・病院、専門クリニック、その他

世界の進行性前立腺がん治療薬市場:地域・国別、2018年-2023年、2024年-2029年
世界の進行性前立腺がん治療薬市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における進行性前立腺がん治療薬のグローバル売上、2018年-2023年
・主要企業における進行性前立腺がん治療薬のグローバル売上シェア、2022年
・主要企業における進行性前立腺がん治療薬のグローバル販売量、2018年-2023年
・主要企業における進行性前立腺がん治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Pfizer、Astellas、Janssen、AstraZeneca、Bayer、Hengrui、CTTQ、Sanofi、Hansoh、Clovis Oncology、Zhendong Pharmaceutical、Merck

*************************************************************

・調査・分析レポートの概要
進行性前立腺がん治療薬市場の定義
市場セグメント
世界の進行性前立腺がん治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の進行性前立腺がん治療薬市場規模
世界の進行性前立腺がん治療薬市場規模:2022年 VS 2029年
世界の進行性前立腺がん治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの進行性前立腺がん治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の進行性前立腺がん治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:経口式、静脈注射式、その他
進行性前立腺がん治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、専門クリニック、その他
進行性前立腺がん治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別進行性前立腺がん治療薬市場規模 2022年と2029年
地域別進行性前立腺がん治療薬売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Pfizer、Astellas、Janssen、AstraZeneca、Bayer、Hengrui、CTTQ、Sanofi、Hansoh、Clovis Oncology、Zhendong Pharmaceutical、Merck

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Advanced Prostate Cancer Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Advanced Prostate Cancer Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Advanced Prostate Cancer Drug Overall Market Size
2.1 Global Advanced Prostate Cancer Drug Market Size: 2022 VS 2029
2.2 Global Advanced Prostate Cancer Drug Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Advanced Prostate Cancer Drug Players in Global Market
3.2 Top Global Advanced Prostate Cancer Drug Companies Ranked by Revenue
3.3 Global Advanced Prostate Cancer Drug Revenue by Companies
3.4 Top 3 and Top 5 Advanced Prostate Cancer Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Advanced Prostate Cancer Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Advanced Prostate Cancer Drug Players in Global Market
3.6.1 List of Global Tier 1 Advanced Prostate Cancer Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Advanced Prostate Cancer Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Advanced Prostate Cancer Drug Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Intravenous Injection
4.1.4 Others
4.2 By Type – Global Advanced Prostate Cancer Drug Revenue & Forecasts
4.2.1 By Type – Global Advanced Prostate Cancer Drug Revenue, 2018-2023
4.2.2 By Type – Global Advanced Prostate Cancer Drug Revenue, 2024-2029
4.2.3 By Type – Global Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Advanced Prostate Cancer Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Specialty Clinic
5.1.4 Others
5.2 By Application – Global Advanced Prostate Cancer Drug Revenue & Forecasts
5.2.1 By Application – Global Advanced Prostate Cancer Drug Revenue, 2018-2023
5.2.2 By Application – Global Advanced Prostate Cancer Drug Revenue, 2024-2029
5.2.3 By Application – Global Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Advanced Prostate Cancer Drug Market Size, 2022 & 2029
6.2 By Region – Global Advanced Prostate Cancer Drug Revenue & Forecasts
6.2.1 By Region – Global Advanced Prostate Cancer Drug Revenue, 2018-2023
6.2.2 By Region – Global Advanced Prostate Cancer Drug Revenue, 2024-2029
6.2.3 By Region – Global Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Advanced Prostate Cancer Drug Revenue, 2018-2029
6.3.2 US Advanced Prostate Cancer Drug Market Size, 2018-2029
6.3.3 Canada Advanced Prostate Cancer Drug Market Size, 2018-2029
6.3.4 Mexico Advanced Prostate Cancer Drug Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Advanced Prostate Cancer Drug Revenue, 2018-2029
6.4.2 Germany Advanced Prostate Cancer Drug Market Size, 2018-2029
6.4.3 France Advanced Prostate Cancer Drug Market Size, 2018-2029
6.4.4 U.K. Advanced Prostate Cancer Drug Market Size, 2018-2029
6.4.5 Italy Advanced Prostate Cancer Drug Market Size, 2018-2029
6.4.6 Russia Advanced Prostate Cancer Drug Market Size, 2018-2029
6.4.7 Nordic Countries Advanced Prostate Cancer Drug Market Size, 2018-2029
6.4.8 Benelux Advanced Prostate Cancer Drug Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Advanced Prostate Cancer Drug Revenue, 2018-2029
6.5.2 China Advanced Prostate Cancer Drug Market Size, 2018-2029
6.5.3 Japan Advanced Prostate Cancer Drug Market Size, 2018-2029
6.5.4 South Korea Advanced Prostate Cancer Drug Market Size, 2018-2029
6.5.5 Southeast Asia Advanced Prostate Cancer Drug Market Size, 2018-2029
6.5.6 India Advanced Prostate Cancer Drug Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Advanced Prostate Cancer Drug Revenue, 2018-2029
6.6.2 Brazil Advanced Prostate Cancer Drug Market Size, 2018-2029
6.6.3 Argentina Advanced Prostate Cancer Drug Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Advanced Prostate Cancer Drug Revenue, 2018-2029
6.7.2 Turkey Advanced Prostate Cancer Drug Market Size, 2018-2029
6.7.3 Israel Advanced Prostate Cancer Drug Market Size, 2018-2029
6.7.4 Saudi Arabia Advanced Prostate Cancer Drug Market Size, 2018-2029
6.7.5 UAE Advanced Prostate Cancer Drug Market Size, 2018-2029
7 Advanced Prostate Cancer Drug Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Advanced Prostate Cancer Drug Major Product Offerings
7.1.4 Pfizer Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Astellas
7.2.1 Astellas Company Summary
7.2.2 Astellas Business Overview
7.2.3 Astellas Advanced Prostate Cancer Drug Major Product Offerings
7.2.4 Astellas Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.2.5 Astellas Key News & Latest Developments
7.3 Janssen
7.3.1 Janssen Company Summary
7.3.2 Janssen Business Overview
7.3.3 Janssen Advanced Prostate Cancer Drug Major Product Offerings
7.3.4 Janssen Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.3.5 Janssen Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Advanced Prostate Cancer Drug Major Product Offerings
7.4.4 AstraZeneca Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Advanced Prostate Cancer Drug Major Product Offerings
7.5.4 Bayer Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 Hengrui
7.6.1 Hengrui Company Summary
7.6.2 Hengrui Business Overview
7.6.3 Hengrui Advanced Prostate Cancer Drug Major Product Offerings
7.6.4 Hengrui Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.6.5 Hengrui Key News & Latest Developments
7.7 CTTQ
7.7.1 CTTQ Company Summary
7.7.2 CTTQ Business Overview
7.7.3 CTTQ Advanced Prostate Cancer Drug Major Product Offerings
7.7.4 CTTQ Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.7.5 CTTQ Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Advanced Prostate Cancer Drug Major Product Offerings
7.8.4 Sanofi Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
7.9 Hansoh
7.9.1 Hansoh Company Summary
7.9.2 Hansoh Business Overview
7.9.3 Hansoh Advanced Prostate Cancer Drug Major Product Offerings
7.9.4 Hansoh Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.9.5 Hansoh Key News & Latest Developments
7.10 Clovis Oncology
7.10.1 Clovis Oncology Company Summary
7.10.2 Clovis Oncology Business Overview
7.10.3 Clovis Oncology Advanced Prostate Cancer Drug Major Product Offerings
7.10.4 Clovis Oncology Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.10.5 Clovis Oncology Key News & Latest Developments
7.11 Zhendong Pharmaceutical
7.11.1 Zhendong Pharmaceutical Company Summary
7.11.2 Zhendong Pharmaceutical Business Overview
7.11.3 Zhendong Pharmaceutical Advanced Prostate Cancer Drug Major Product Offerings
7.11.4 Zhendong Pharmaceutical Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.11.5 Zhendong Pharmaceutical Key News & Latest Developments
7.12 Merck
7.12.1 Merck Company Summary
7.12.2 Merck Business Overview
7.12.3 Merck Advanced Prostate Cancer Drug Major Product Offerings
7.12.4 Merck Advanced Prostate Cancer Drug Revenue in Global Market (2018-2023)
7.12.5 Merck Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Advanced Prostate Cancer Drug Market Opportunities & Trends in Global Market
Table 2. Advanced Prostate Cancer Drug Market Drivers in Global Market
Table 3. Advanced Prostate Cancer Drug Market Restraints in Global Market
Table 4. Key Players of Advanced Prostate Cancer Drug in Global Market
Table 5. Top Advanced Prostate Cancer Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Advanced Prostate Cancer Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Advanced Prostate Cancer Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Advanced Prostate Cancer Drug Product Type
Table 9. List of Global Tier 1 Advanced Prostate Cancer Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Advanced Prostate Cancer Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Advanced Prostate Cancer Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Advanced Prostate Cancer Drug Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Advanced Prostate Cancer Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Advanced Prostate Cancer Drug Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Advanced Prostate Cancer Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Advanced Prostate Cancer Drug Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Advanced Prostate Cancer Drug Product Offerings
Table 32. Pfizer Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Astellas Company Summary
Table 35. Astellas Advanced Prostate Cancer Drug Product Offerings
Table 36. Astellas Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 37. Astellas Key News & Latest Developments
Table 38. Janssen Company Summary
Table 39. Janssen Advanced Prostate Cancer Drug Product Offerings
Table 40. Janssen Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Janssen Key News & Latest Developments
Table 42. AstraZeneca Company Summary
Table 43. AstraZeneca Advanced Prostate Cancer Drug Product Offerings
Table 44. AstraZeneca Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 45. AstraZeneca Key News & Latest Developments
Table 46. Bayer Company Summary
Table 47. Bayer Advanced Prostate Cancer Drug Product Offerings
Table 48. Bayer Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Bayer Key News & Latest Developments
Table 50. Hengrui Company Summary
Table 51. Hengrui Advanced Prostate Cancer Drug Product Offerings
Table 52. Hengrui Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Hengrui Key News & Latest Developments
Table 54. CTTQ Company Summary
Table 55. CTTQ Advanced Prostate Cancer Drug Product Offerings
Table 56. CTTQ Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 57. CTTQ Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Advanced Prostate Cancer Drug Product Offerings
Table 60. Sanofi Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Hansoh Company Summary
Table 63. Hansoh Advanced Prostate Cancer Drug Product Offerings
Table 64. Hansoh Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Hansoh Key News & Latest Developments
Table 66. Clovis Oncology Company Summary
Table 67. Clovis Oncology Advanced Prostate Cancer Drug Product Offerings
Table 68. Clovis Oncology Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Clovis Oncology Key News & Latest Developments
Table 70. Zhendong Pharmaceutical Company Summary
Table 71. Zhendong Pharmaceutical Advanced Prostate Cancer Drug Product Offerings
Table 72. Zhendong Pharmaceutical Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 73. Zhendong Pharmaceutical Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Advanced Prostate Cancer Drug Product Offerings
Table 76. Merck Advanced Prostate Cancer Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Merck Key News & Latest Developments
List of Figures
Figure 1. Advanced Prostate Cancer Drug Segment by Type in 2022
Figure 2. Advanced Prostate Cancer Drug Segment by Application in 2022
Figure 3. Global Advanced Prostate Cancer Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Advanced Prostate Cancer Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Advanced Prostate Cancer Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Advanced Prostate Cancer Drug Revenue in 2022
Figure 8. By Type - Global Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 9. By Application - Global Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 10. By Type - Global Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 12. By Application - Global Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 14. By Region - Global Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 15. By Country - North America Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 16. US Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 20. Germany Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 21. France Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 28. China Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 32. India Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 34. Brazil Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Advanced Prostate Cancer Drug Revenue Market Share, 2018-2029
Figure 37. Turkey Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Advanced Prostate Cancer Drug Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Astellas Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Janssen Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. AstraZeneca Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bayer Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Hengrui Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. CTTQ Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sanofi Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Hansoh Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Clovis Oncology Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Zhendong Pharmaceutical Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Merck Advanced Prostate Cancer Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



★調査レポート[世界の進行性前立腺がん治療薬市場予測2023-2029:経口式、静脈注射式、その他] (コード:MMG23FB2153)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の進行性前立腺がん治療薬市場予測2023-2029:経口式、静脈注射式、その他]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆